floxacillin has been researched along with cefazolin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 6 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Adam, D | 1 |
| Claessens, H; Myny, P; Paeme, G; Van Meirhaeghe, J; Verdonk, R; Verschraegen, G | 1 |
| Cerisier, A; Chevalier, P; Cucherat, M; Da Costa, A; Delahaye, F; Isaaz, K; Kirkorian, G; Touboul, P | 1 |
| Banky, JP; Ostergaard, L; Spelman, D | 1 |
| Chatfield, M; Cheng, AC; Davis, JS; Fowler, VG; Howden, BP; Lipman, J; Lye, D; Nelson, J; O'Sullivan, M; Paterson, DL; Robinson, JO; Tong, SY; Van Hal, S; Yahav, D | 1 |
| Buclin, T; Cochet, C; de Valliere, S; Decosterd, L; Gardiol, C; Van Neyghem, N; Voumard, R | 1 |
| Davis, JS; Tong, S; Turnidge, J | 1 |
| Begg, EJ; Chin, PKL; Everts, R; Moore, GA; Zhang, M | 1 |
| Adam, T; Bachmann, F; Budde, K; Friedersdorff, F; Liefeldt, L; Slowinski, T; Waiser, J | 1 |
| Bamal, R; Bindra, R; Matthews, J; McLean, A | 1 |
| Fonville, JM; Heineken, AC; Hendriks, JGE; Van Der Steen, MCM; Van Erp, JHJ; Van Kempen, RWTM; Van Wensen, RJA; Wegdam-Blans, M | 1 |
| Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
| Jamieson, C; Jenkins, A; Santillo, M; Shanu, S | 1 |
| Greisen, G; Gupta, M; Jakobsen, JC; Korang, SK; Lausten-Thomsen, U; Nava, C; Safi, S | 1 |
| Doogue, M; Jensen, BP; Mortensen, JS | 1 |
| Kinuthia, RN; Murila, BL; Njogu, PM; Nyamu, DG | 1 |
| Campbell, PO; Chambers, ST; Chin, PKL; Dalton, SC; Douglas, NM; Metcalf, SCL | 1 |
5 review(s) available for floxacillin and cefazolin
| Article | Year |
|---|---|
Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antibiotic Prophylaxis; Cefazolin; Cloxacillin; Double-Blind Method; Female; Floxacillin; Humans; Incidence; Male; Middle Aged; Pacemaker, Artificial; Penicillin G; Prospective Studies; Randomized Controlled Trials as Topic; Sepsis; Surgical Wound Infection; Treatment Outcome | 1998 |
Chronic relapsing salmonella osteomyelitis in an immunocompetent patient: case report and literature review.
Topics: Adult; Anti-Infective Agents; Cefazolin; Ceftriaxone; Cephalosporins; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Floxacillin; Humans; Immunocompetence; Male; Osteomyelitis; Penicillins; Recurrence; Salmonella; Salmonella Infections; Time Factors | 2002 |
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Ceftazidime; Floxacillin; Humans; Outpatients; Piperacillin; State Medicine; Tazobactam | 2022 |
Antibiotic regimens for late-onset neonatal sepsis.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bias; Cefazolin; Clavulanic Acid; Drug Therapy, Combination; Floxacillin; Gentamicins; Humans; Infant, Newborn; Neonatal Sepsis; Randomized Controlled Trials as Topic; Ticarcillin; Vancomycin | 2021 |
Preanalytical Stability of Flucloxacillin, Piperacillin, Tazobactam, Meropenem, Cefalexin, Cefazolin, and Ceftazidime in Therapeutic Drug Monitoring: A Structured Review.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalexin; Drug Monitoring; Drug Stability; Floxacillin; Humans; Meropenem; Piperacillin; Tazobactam | 2022 |
3 trial(s) available for floxacillin and cefazolin
| Article | Year |
|---|---|
Flucloxacillin compared with cefazolin in short-term prophylaxis for clean orthopedic surgery.
Topics: Adolescent; Aged; Cefazolin; Cloxacillin; Double-Blind Method; Female; Floxacillin; Humans; Male; Middle Aged; Orthopedics; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection | 1989 |
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
16 other study(ies) available for floxacillin and cefazolin
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Recent antibiotics. Range of action, indications, dosage].
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbenicillin; Cefazolin; Cephacetrile; Cephalexin; Cephalosporins; Cephradine; Child; Child, Preschool; Cyclacillin; Doxycycline; Floxacillin; Humans; Infant; Infant, Newborn; Minocycline; Penicillin G; Pivampicillin; Tetracyclines; Trimethoprim | 1975 |
Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT).
Topics: Anti-Bacterial Agents; Cefazolin; Cefepime; Cephalosporins; Drug Stability; Elastomers; Female; Floxacillin; Healthy Volunteers; Humans; Infusion Pumps; Male; Piperacillin; Polymers; Temperature | 2017 |
A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefazolin; Child; Child, Preschool; Female; Floxacillin; Gene Expression; Humans; Infant; Male; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome | 2018 |
Simultaneous Determination of Cefalexin, Cefazolin, Flucloxacillin, and Probenecid by Liquid Chromatography-Tandem Mass Spectrometry for Total and Unbound Concentrations in Human Plasma.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactams; Cefazolin; Cephalexin; Child; Chromatography, High Pressure Liquid; Drug Monitoring; Floxacillin; Humans; Limit of Detection; Middle Aged; Plasma; Probenecid; Tandem Mass Spectrometry; Young Adult | 2018 |
Perioperative antibiotic prophylaxis in renal transplantation: a single-center comparison between two regimens and a brief survey among the Eurotransplant renal transplantation centers.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Escherichia coli Infections; Europe; Female; Floxacillin; Humans; Kidney Transplantation; Male; Middle Aged; Perioperative Care; Piperacillin; Postoperative Complications; Retrospective Studies; Sepsis; Sex Factors; Sulbactam; Surgical Wound Infection; Surveys and Questionnaires; Urinary Tract Infections | 2019 |
Bacteriological profile of community-acquired musculoskeletal infections: a study from Queensland.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Australia; Cefazolin; Child; Child, Preschool; Community-Acquired Infections; Female; Floxacillin; Hospitalization; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Musculoskeletal Diseases; Osteomyelitis; Queensland; Retrospective Studies; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Young Adult | 2018 |
Optimization of the empirical antibiotic choice during the treatment of acute prosthetic joint infections: a retrospective analysis of 91 patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Clinical Decision-Making; Combined Modality Therapy; Debridement; Female; Floxacillin; Hip Prosthesis; Humans; Knee Prosthesis; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Practice Patterns, Physicians'; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections | 2019 |
Rational use of antibiotics and covariates of clinical outcomes in patients admitted to intensive care units of a tertiary hospital in Kenya.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Cefuroxime; Floxacillin; Humans; Intensive Care Units; Kenya; Tertiary Care Centers | 2022 |
Frequency of pharmacological target attainment with flucloxacillin and cefazolin in invasive methicillin-susceptible Staphylococcus aureus infection: a prospective cohort study in hospitalized patients.
Topics: Anti-Bacterial Agents; Cefazolin; Floxacillin; Humans; Methicillin; Microbial Sensitivity Tests; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2023 |